We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia.
- Authors
Nolan, Brendan J.; Cheung, Ada S.
- Abstract
Gender‐affirming hormone therapy (GAHT) is used by many transgender and gender‐diverse adults to align physical characteristics with their gender identity, reduce gender incongruence and improve psychological functioning. This narrative review provides an overview of the initiation and monitoring of GAHT in an Australian context. Trans individuals treated with testosterone typically receive standard testosterone doses and formulations recommended for cisgender men, whereas those receiving estradiol GAHT are typically treated with estradiol in combination with an anti‐androgen in those without orchidectomy. Proactive monitoring and mitigation of cardiovascular risk factors is pertinent in all transgender and gender‐diverse adults and bone health is an important consideration in those using estradiol GAHT.
- Subjects
AUSTRALIA; GENDER-nonconforming people; TESTOSTERONE; ANTIANDROGENS; COMBINATION drug therapy; PROGESTERONE; AUSTRALIANS; BONE density; GENDER affirming care; EARLY detection of cancer; TREATMENT effectiveness; CARDIOVASCULAR diseases risk factors; ESTRADIOL; HORMONE therapy; GENDER dysphoria; CISGENDER people; PSYCHOSOCIAL functioning
- Publication
Internal Medicine Journal, 2024, Vol 54, Issue 9, p1450
- ISSN
1444-0903
- Publication type
Article
- DOI
10.1111/imj.16413